Tuesday, April 22, 2014
Chief Justice Roberts Refuses to Block Ruling Canceling Teva Patent
U.S. Chief Justice John Roberts refused Friday to block a lower-court ruling that invalidated Teva Pharmaceutical Industries Ltd.’s patent for the multiple sclerosis drug Copaxone while the Israeli drugmaker pursues an appeal to the Supreme Court.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment